AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $17,000 | -10.5% | 27,000 | +22.7% | 0.00% | – |
Q3 2019 | $19,000 | +137.5% | 22,000 | +83.3% | 0.00% | – |
Q2 2019 | $8,000 | +60.0% | 12,000 | +500.0% | 0.00% | – |
Q2 2018 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
Caption Management, LLC | 748,200 | $503,000 | 0.02% |
Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |